286 related articles for article (PubMed ID: 25532434)
1. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
3. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
4. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Honda M; Kaito A; Daiko H; Kinoshita T
Anticancer Res; 2014 Aug; 34(8):4391-7. PubMed ID: 25075076
[TBL] [Abstract][Full Text] [Related]
5. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
Anticancer Res; 2015 Jan; 35(1):445-56. PubMed ID: 25550586
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
7. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
[TBL] [Abstract][Full Text] [Related]
9. Risk factor of mediastinal lymph node metastasis of Siewert type I and II esophagogastric junction carcinomas.
Nishiwaki N; Noma K; Matsuda T; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
Langenbecks Arch Surg; 2020 Dec; 405(8):1101-1109. PubMed ID: 33155069
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
13. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting recurrence in patients with Siewert type II carcinoma treated with curative resection.
Fukuchi M; Mochiki E; Suzuki O; Ishiguro T; Sobajima J; Onozawa H; Imaizumi H; Shibata K; Saito K; Naitoh H; Kumagai Y; Ishibashi K; Ishida H
Anticancer Res; 2015 Jan; 35(1):505-9. PubMed ID: 25550595
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of lymph node metastasis in Siewert type II adenocarcinoma of the gastroesophageal junction].
Li SM; Li ZY; Ji X
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):288-91. PubMed ID: 23985258
[TBL] [Abstract][Full Text] [Related]
17. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
[TBL] [Abstract][Full Text] [Related]
18. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
19. New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.
Zheng B; Ni CH; Chen H; Wu WD; Guo ZH; Zhu Y; Zheng W; Chen C
Medicine (Baltimore); 2017 Apr; 96(14):e6533. PubMed ID: 28383418
[TBL] [Abstract][Full Text] [Related]
20. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
